NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-308-2000-0-US-11 Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same US DIV 13/190,969 Abandoned
NCI E-188-2011-0-US-01 HIV Integrase Inhibitory Oxoisoindoline Sulfonamides US 61/511,916 Abandoned
NCI E-217-2010-2-PCT-01 A Method For The Treatment Of Obesity PCT PCT COMB PCT/US2011/044975 Expired
NIAID E-184-2010-0-EP-03 METHOD OF PREVENTING OR TREATING VIRAL INFECTION EP National Stage 11738131.9 Abandoned
NIAID E-184-2010-0-PCT-02 METHOD OF PREVENTING OR TREATING VIRAL INFECTION PCT PCT PCT/US2011/044835 Expired
NCATS E-294-2009-0-EP-03 Use Of Delta Tocopherol For The Treatment Of Lysosomal Storage Disorders EP National Stage 11741023.3 Issued
NIA E-049-2001-0-HK-29 GLP-1, EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF HK EP 11107548.9 Expired
NCATS E-294-2009-0-PCT-02 Use Of Delta Tocopherol For The Treatment Of Lysosomal Storage Disorders PCT PCT PCT/US2011/044590 Expired
NHGRI E-272-2008-0-US-05 Use of ERBB4 As A Prognostic And Therapeutic Marker For Melanoma US National Stage 13/128,125 8652787 Abandoned PDF
NCI E-168-2011-0-US-01 Methods And Compositions For Inhibiting Polyomavirus-Associated Pathology US 61/508,897 Abandoned
NCATS E-187-2009-2-AU-04 ORGANIC COMPOUNDS AU National Stage 2011279008 Abandoned
NCATS E-187-2009-2-PCT-01 ORGANIC COMPOUNDS PCT PCT COMB PCT/US2011/044267 Expired
NCATS E-187-2009-2-EP-03 ORGANIC COMPOUNDS EP National Stage 11807604.1 Abandoned
NCATS E-187-2009-2-CA-05 ORGANIC COMPOUNDS (ANTI-PLATELET AGENTS) CA National Stage 2805724 Abandoned
NCI E-025-2009-0-US-03 Ratio Based Biomarkers And Methods of Use Thereof US National Stage 13/144,474 Abandoned
NCI E-172-2011-0-US-01 Identification Of Genetic Background-independent Early Noninvasive Biomarkers For Alcoholic Liver Disease Using Urinary Matabolomics And The Ppara-null Mouse US 61/507,573 Abandoned
NCI E-025-2009-0-IL-07 Ratio Based Biomarkers And Methods of Use Thereof IL National Stage 214046 Issued
NIAID E-019-2007-2-US-11 Vaccines Against Potential Pandemic Strains Of Influenza US DIV 13/230,203 8431137 Abandoned PDF
NIDDK E-234-2011-0-US-01 Conjugating Amines US 61/507,054 Abandoned
NCI E-190-2002-2-US-04 Identification Of A Novel BHD Gene US DIV 13/179,853 8865880 Abandoned PDF
NCI E-205-2010-1-US-01 Photosensitizing Antibody-Fluorophore Conjugates US CIP 13/180,111 8524239 Issued PDF
NINDS E-301-2007-0-US-09 Transcranial Magnetic Stimulation System And Methods US DIV 13/179,524 8388510 Expired PDF
NCI E-275-2002-1-US-06 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy US DIV 13/178,644 8287857 Expired PDF
NHGRI E-187-2011-0-US-01 METHODS FOR DETECTING ADHD SUSCEPTIBILITY AND PREDICTING SEVERITY AND LONG TERM OUTCOME OF ADHD SYMPTOMS US 61/505,864 Abandoned
NCI E-321-2003-0-US-08 Human Cytotoxic T-Lymphocyte Epitope And It's Agonist Epitope From The Non-Variable Number of Tandem Repeat Sequence of MUC-1 US DIV 13/176,341 8957192 Expired PDF
NCI E-249-2005-0-US-05 Treating Renal Cancer Using A 4-[BIS[2-[(Methylsulfonyl)OXY]ETHYL]AMINO]-2-METHYL-BENZALDEHYDE US CON 13/176,129 8273797 Abandoned PDF
NHLBI E-114-2010-0-PCT-02 Active Adaptive Detuning Systems And Methods For Interventional MRI Devices PCT PCT PCT/US2011/042746 Expired
NHGRI E-209-2011-0-US-01 ACSF3 Mutations in Metabolic Disorders7/1/2012 US 61/504,030 Abandoned
NHGRI E-116-2011-0-US-01 Method of Treating Pathologic Heterotopic Ossification (HO) US 61/504,041 Abandoned
NIAID E-219-2014-0-US-01 Compounds For Inhibiting 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase US 61/503,736 Abandoned
NCI E-194-2008-0-US-03 Immunotoxins And Uses Thereof US National Stage 12/996,138 Abandoned
NIBIB E-118-2010-0-PCT-02 System and Method of Producing Nondiffracting Light Sheets By A Multiplicity Of Spatially Overlapping, Minimally Interfering Nondiffracting Optical Beams PCT PCT PCT/US2011/042495 Abandoned
NINDS E-251-2005-0-CA-04 SYSTEMS AND METHODS FOR RECOVERY OF MOTOR CONTROL VIA STIMULATION TO A SUBSTITUTED SITE FOR AN AFFECTED AREA CA National Stage 2614072 Issued
NIAID E-213-2010-2-PCT-01 HIV Immunogens PCT PCT COMB PCT/US2011/042434 Expired
NEI E-092-2010-0-EP-05 Methods of Treatment Using Sterculic Acid EP National Stage 11731200.9 Abandoned
NEI E-092-2010-0-GB-09 Methods of Treatment Using Sterculic Acid GB EP 11731200.9 Abandoned
NEI E-092-2010-0-DE-07 Methods of Treatment Using Sterculic Acid DE EP 11731200.9 Abandoned
NEI E-092-2010-0-FR-08 Methods of Treatment Using Sterculic Acid FR EP 11731200.9 Abandoned
NEI E-092-2010-0-AU-03 Methods of Treatment Using Sterculic Acid AU National Stage 2011270754 Abandoned
NEI E-092-2010-0-PCT-02 Methods of Using Sterculic Acid PCT PCT PCT/US2011/041766 Expired
CC E-078-2005-0-US-01 Electrically Conductive Catheter That Inhibits Biological Barrier Formation US 61/501,065 Abandoned
NIAID E-057-2011-1-US-01 VIRUS-LIKE PARTICLES AND METHODS OF USE US 61/501,012 Abandoned
NEI E-092-2010-0-CA-04 Methods of Using Sterculic Acid CA National Stage 2803923 Abandoned
NCI E-100-2010-0-PCT-02 REGULATION OF SKIN PIGMENTATION BY NEUREGULIN-1 (NRG-1) PCT PCT PCT/US2011/041610 Expired
NCI E-159-2011-1-US-01 Novel Chalcone Derivative As Potent Activator Of Nrf2 Signaling US 61/500,272 Abandoned
NIAID E-323-2005-2-AU-11 Influenza Hemagglutinin And Neuraminidase Variants AU DIV 2011202991 Abandoned
NCI E-196-2011-1-US-01 Use of Frizzled Receptor Expression In Measuring Effect of SFRP on WNT/BETA-CATENIN Signaling US 61/499,684 Abandoned
CC E-093-2005-0-CA-04 DEVICE AND METHOD FOR A TRACKABLE ULTRASOUND CA National Stage 2612603 Issued
NINDS E-251-2005-0-FR-16 Systems for recovery of motor control via stimulation to a substitute site for an affected area FR EP 11005014.3 Issued
NINDS E-251-2005-0-DE-15 Systems for recovery of motor control via stimulation to a substitute site for an affected area DE EP 11005014.3 Issued